Perez SA - Search Results

1

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.

Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: perez sa. Cancer Immunol Immunother. 2009 Mar;58(3):317-24. doi: 10.1007/s00262-008-0576-4. Epub 2008 Aug 15. Cancer Immunol Immunother. 2009. PMID: 18704409 Review.

2

delta IK17: an antigen expressed on human lymphocytes.

Sotiriadou R, Kokkinopoulos D, Stinios J, Dimas C, Trangas T, Perez S. Sotiriadou R, et al. Int J Biol Markers. 1996 Oct-Dec;11(4):183-9. Int J Biol Markers. 1996. PMID: 9017440

3

delta IK17 antigen: a possible early marker of cancer development.

Perez S, Sotiriadou R, Missitzis G, Trangas T, Giannoulis N, Mavroudeas D, Apostolikas N, Kokkinopoulos D. Perez S, et al. Int J Biol Markers. 1996 Oct-Dec;11(4):190-7. Int J Biol Markers. 1996. PMID: 9017441

4

Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.

Sotiriadou R, Perez SA, Gritzapis AD, Sotiropoulou PA, Echner H, Heinzel S, Mamalaki A, Pawelec G, Voelter W, Baxevanis CN, Papamichail M. Sotiriadou R, et al. Among authors: perez sa. Br J Cancer. 2001 Nov 16;85(10):1527-34. doi: 10.1054/bjoc.2001.2089. Br J Cancer. 2001. PMID: 11720440 Free PMC article.

5

HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones.

Perez SA, Sotiropoulou PA, Sotiriadou NN, Mamalaki A, Gritzapis AD, Echner H, Voelter W, Pawelec G, Papamichail M, Baxevanis CN. Perez SA, et al. Cancer Immunol Immunother. 2002 Jan;50(11):615-24. doi: 10.1007/s002620100225. Epub 2001 Nov 23. Cancer Immunol Immunother. 2002. PMID: 11807625

6

Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells.

Gritzapis AD, Mamalaki A, Kretsovali A, Papamatheakis J, Belimezi M, Perez SA, Baxevanis CN, Papamichail M. Gritzapis AD, et al. Among authors: perez sa. Br J Cancer. 2003 Apr 22;88(8):1292-300. doi: 10.1038/sj.bjc.6600888. Br J Cancer. 2003. PMID: 12698199 Free PMC article.

7

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the gamma-chain from Fc(epsilon) RI.

Mamalaki A, Gritzapis AD, Kretsovali A, Belimezi M, Papamatheakis J, Perez SA, Papamichail M, Baxevanis CN. Mamalaki A, et al. Among authors: perez sa. Cancer Immunol Immunother. 2003 Aug;52(8):513-22. doi: 10.1007/s00262-002-0371-6. Epub 2003 Apr 25. Cancer Immunol Immunother. 2003. PMID: 12715240

8

Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours.

Sotiropoulou PA, Perez SA, Iliopoulou EG, Missitzis I, Voelter V, Echner H, Baxevanis CN, Papamichail M. Sotiropoulou PA, et al. Among authors: perez sa. Br J Cancer. 2003 Sep 15;89(6):1055-61. doi: 10.1038/sj.bjc.6601244. Br J Cancer. 2003. PMID: 12966425 Free PMC article.

9

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.

Sotiropoulou PA, Perez SA, Voelter V, Echner H, Missitzis I, Tsavaris NB, Papamichail M, Baxevanis CN. Sotiropoulou PA, et al. Among authors: perez sa. Cancer Immunol Immunother. 2003 Dec;52(12):771-9. doi: 10.1007/s00262-003-0420-9. Epub 2003 Sep 10. Cancer Immunol Immunother. 2003. PMID: 13680193

10

Natural killer lymphocytes: biology, development, and function.

Papamichail M, Perez SA, Gritzapis AD, Baxevanis CN. Papamichail M, et al. Among authors: perez sa. Cancer Immunol Immunother. 2004 Mar;53(3):176-86. doi: 10.1007/s00262-003-0478-4. Epub 2003 Dec 18. Cancer Immunol Immunother. 2004. PMID: 14685782 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results